World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
81
Citations
25221
World Ranking
1090
National Ranking
496

Medicine

D-Index
83
Citations
25585
World Ranking
15592
National Ranking
7855

Brian D. Plikaytis publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Brian D. Plikaytis sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 158 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Brian D. Plikaytis D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Brian D. Plikaytis sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 81 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Brian D. Plikaytis is affiliated with the Centers for Disease Control and Prevention in the United States. Their research focuses primarily on the field of Medicine, with substantial work in several subfields including Infectious Diseases, Hepatology, Cardiology and Cardiovascular Medicine, Epidemiology, and Animal Science and Zoology.

The scientist's main topics of research comprise viral gastroenteritis research and epidemiology, hepatitis viruses studies and epidemiology, viral infections and immunology research, animal virus infections studies, bacterial infections and vaccines, SARS-CoV-2 and COVID-19 research, and congenital anomalies and fetal surgery.

Brian D. Plikaytis has contributed to several scientific publications. Notable papers include:

  • Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial, 2021, PLoS Medicine
  • Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial, 2021, PLoS Medicine
  • Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant, 2021, Journal of Immunological Methods
  • Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency, 2022, Vaccine
  • Correction: Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial, 2021, PLoS Medicine

The scientist frequently collaborates with other researchers, with some of the most common coauthors including Sheila Isanaka, Céline Langendorf, Souna Garba, Ousmane Guindo, and Rebecca F. Grais.

Brian D. Plikaytis's work is published in a range of venues, notably:

  • PLoS Medicine
  • Vaccine
  • Journal of Immunological Methods
  • Vaccines
  • SSRN Electronic Journal

Best Publications

  • Pasteurized milk as a vehicle of infection in an outbreak of listeriosis.

    David W. Fleming;Stephen L. Cochi;Kristine L. MacDonald;Jack Brondum

  • Epidemic Listeriosis Associated with Mexican-Style Cheese

    M J Linnan;L Mascola;X D Lou;V Goulet

  • Genotypic identification of rickettsiae and estimation of intraspecies sequence divergence for portions of two rickettsial genes

    Unknown

  • Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

    W G Adams;K A Deaver;S L Cochi;B D Plikaytis

  • Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997

    Michael M. McNeil;Stephanie L. Nash;Rana A. Hajjeh;Maureen A. Phelan

  • Cat Scratch Disease in Connecticut -- Epidemiology, Risk Factors, and Evaluation of a New Diagnostic Test

    Kenneth M. Zangwill;Douglas H. Hamilton;Bradley A. Perkins;Russell L. Regnery

  • Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.

    Jordan W. Tappero;Rosanna Lagos;Aurora Maldonado Ballesteros;Brian Plikaytis

  • Clonal nature of Salmonella typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme electrophoresis, and proposal of Salmonella bongori comb. nov.

    M W Reeves;G M Evins;A A Heiba;B D Plikaytis

  • Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance

    Juliette Morgan;Martin I. Meltzer;Brian D. Plikaytis;Andre N. Sofair

  • Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil.

    J. Cassio de Moraes;M.C.C. Camargo;N.T. Rossetto Hidalgo;H. Aparecida Barbosa

  • Reduction in Functional Antibody Activity Against Streptococcus pneumoniae in Vaccinated Elderly Individuals Highly Correlates with Decreased IgG Antibody Avidity

    Sandra Romero-Steiner;Daniel M. Musher;Marty S. Cetron;Lorna B. Pais

  • Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.

    Luis Jódar;Jay Butler;George Carlone;Ron Dagan

  • Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group.

    A Schuchat;K A Deaver;J D Wenger;B D Plikaytis

  • Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

    Catherine M. Wernette;Carl E. Frasch;Dace Madore;George Carlone

  • Enzyme-Linked Immunosorbent Assay and Indirect Immunofluorescence Assay for Lyme Disease

    Harold Russell;Jacquelyn S. Sampson;George P. Schmid;Hazel W. Wilkinson

  • Antimicrobial Resistance of Streptococcus pneumoniae in the United States, 1979–1987

    John S. Spika;Richard R. Facklam;Brian D. Plikaytis;Margaret J. Oxtoby

  • Risk factors for group B streptococcal disease in adults

    Lisa A. Jackson;Roberta Hilsdon;Monica M. Farley;Lee H. Harrison

  • Evaluation of Four Commercially Available Rapid Serologic Tests for Diagnosis of Leptospirosis

    Mary D. Bajani;David A. Ashford;Sandra L. Bragg;Christopher W. Woods

  • Pneumococcal Vaccine Efficacy in Selected Populations in the United States

    Gail Bolan;Claire V. Broome;Richard R. Facklam;Brian D. Plikaytis

  • On the Use of Zero-Inflated and Hurdle Models for Modeling Vaccine Adverse Event Count Data

    C E Rose;S W Martin;K A Wannemuehler;B D Plikaytis

  • Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group.

    R W Pinner;A Schuchat;B Swaminathan;P S Hayes

  • Role of Foods in Sporadic Listeriosis. I. Case-Control Study of Dietary Risk Factors

    Anne Schuchat;Katherine A. Deaver;Jay D. Wenger;Brian D. Plikaytis

Frequent Co-Authors

Jay D. Wenger
Jay D. Wenger Centers for Disease Control and Prevention
George M. Carlone
George M. Carlone Centers for Disease Control and Prevention
Claire V. Broome
Claire V. Broome Centers for Disease Control and Prevention
Anne Schuchat
Anne Schuchat Centers for Disease Control and Prevention
Arthur L. Reingold
Arthur L. Reingold University of California, Berkeley
Conrad P. Quinn
Conrad P. Quinn Centers for Disease Control and Prevention
Ray Borrow
Ray Borrow Manchester Royal Infirmary
Robert E. Weaver
Robert E. Weaver Centers for Disease Control and Prevention
David Goldblatt
David Goldblatt University College London
Tanja Popovic
Tanja Popovic Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their education beyond microbiology, there are numerous online healthcare degrees that complement this field. These options provide flexibility for students looking to enhance their expertise while balancing other commitments.

One practical pathway is exploring the best fastest online medical billing and coding certificate programs. These certifications help microbiology graduates pursue careers in healthcare administration and medical records management, offering quicker entry into the workforce.

Another route to consider is public health with easy MPH online programs. A Master of Public Health degree complements microbiology knowledge and opens doors to roles in epidemiology, community health, and healthcare policy.

Career options can also extend into specialty areas such as child life services. Understanding the financial prospects and requirements in this field through resources like how much do child life specialists make can guide career decisions for those interested in healthcare support roles.

Overall, leveraging online degree programs and supplementary certifications can lead to diverse career pathways, ensuring microbiology students stay versatile and competitive in the evolving healthcare landscape.

Best Scientists Citing Brian D. Plikaytis

Trending Scientists

Recently Published Articles